8 years ago The UK Cystic Fibrosis Gene Therapy Consortium, Boehringer Ingelheim, Imperial Innovations and Oxford BioMedica Announce New Partnership to Develop First-In-Class Gene Therapy for Cystic Fibrosis
8 years ago Flutterby Fundraisers to Sponsor Consortium Scientist
9 years ago New Publication - Gelinas et al 2017 - Media Supplements to Improve Lentiviral Vector Production Yields
9 years ago Gene Therapy Funding Update
9 years ago Consortium Student Live Facebook Interview from ASGCT
9 years ago
Hype Cycles and Technological Maturity - BSGCT Presentation
Wednesday, March 26th 2014
Natasha Davie, one of our PhD students in Oxford presented a different kind of poster at the 2014 British Society for Gene and Cell Therapy Conference in London.
Our other PhD students have lab based research projects directly or indirectly aligned with the Consortium's core aims but Natasha is different because her PhD is funded by the SENS Research Foundation and her PhD is being jointly run with the Centre for the Advancement of Sustainable Medical Innovation (CASMI). CASMI is a partnership between Oxford University and UCL, created to develop new models for medical innovation.
Natasha is researching gene therapy as a whole and trying to gain an understanding as to why greater progress has not been made with this technology to date.
In her poster presentation she compares the development of gene therapy now, with that of bone marrow transplantation in the 1960s-1980s.
You can download her poster at the link below:-
Gene Therapy: Barriers to Translation. Davie N et al.
Laboratory Automation (2007): Our Biomek NX is used to purify RNA/DNA from samples and also to setup a range of assays in the lab. The precision of the 'robot' is greater than human pipetting and allows us to massively increase the throughput of sample processing. More...
